1. 10 years clinical outcome of TKIs in EGFR-mutant advanced NSCLC – UHNM experience. (June 2021) Authors: Elmasry, Abdelfattah; Hasanthi, Nillegoda; Giridharan, Selvaraj; Vengalil, Salil; Jegannathen, Apurna Journal: Lung cancer Issue: Volume 156(2021)Supplement 1 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022) Authors: Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;... Journal: Lancet Issue: Volume 399:Issue 10323(2022) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476). Issue 3 (16th May 2022) Authors: James, Nicholas D.; Clarke, Noel W.; Cook, Adrian; Ali, Adnan; Hoyle, Alex P.; Attard, Gerhardt; Brawley, Christopher D.; Chowdhury, Simon; Cross, William R.; Dearnaley, David P.; de Bono, Johann S.; Diaz‐Montana, Carlos; Gilbert, Duncan; Gillessen, Silke; Gilson, Clare; Jones, Rob J.; Langley, R... Journal: International journal of cancer Issue: Volume 151:Issue 3(2022) Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy. (1st February 2016) Authors: Vengalil, Salil; Giuliani, Meredith E.; Huang, Shao Hui; McNiven, Andrea; Song, Yuyao; Xu, Wei; Chan, Biu; Hope, Andrew; Cho, John; Bayley, Andrew; Ringash, Jolie; Goldstein, David; Razak, Albiruni; Irish, Jonathan; Gilbert, Ralph; Gullane, Patrick; Waldron, John; Kim, John; O'Sullivan, Brian Journal: Head & neck Issue: Volume 38(2016)Supplement 1 Page Start: E2035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Issue 9 (September 2022) Authors: Powles, Thomas; Tomczak, Piotr; Park, Se Hoon; Venugopal, Balaji; Ferguson, Thomas; Symeonides, Stefan N; Hajek, Jaroslav; Gurney, Howard; Chang, Yen-Hwa; Lee, Jae Lyun; Sarwar, Naveed; Thiery-Vuillemin, Antoine; Gross-Goupil, Marine; Mahave, Mauricio; Haas, Naomi B; Sawrycki, Piotr; Burgents, Jo... Journal: Lancet oncology Issue: Volume 23:Issue 9(2022) Page Start: 1133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial. Issue 8 (10th March 2022) Authors: Rush, Hannah L.; Murphy, Laura; Morgans, Alicia K.; Clarke, Noel W.; Cook, Adrian D.; Attard, Gerhardt; Macnair, Archie; Dearnaley, David P.; Parker, Christopher C.; Russell, J. Martin; Gillessen, Silke; Matheson, David; Millman, Robin; Brawley, Christopher D.; Pugh, Cheryl; Tanguay, Jacob S.; Jo... Journal: Journal of clinical oncology Issue: Volume 40:Issue 8(2022) Page Start: 825 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗